From: Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects
Category
Group A (n=66)
Group B (n=70)
χ2 value
p value
Survival rate
47 (77.27)
60 (85.71)
4.259
0.039
Recurrence rate
13 (19.70)
5 (7.14)
4.662
0.030
Metastasis rate
15 (22.73)
7 (10.00)
4.058
0.044